# OnCo record nct04417530 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct04417530/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct04417530", "NCT04417530" ;
  schema:name "Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma"@en ;
  schema:description "A phase 2 trial of Belzupacap sarotalocan run by Aura Biosciences, completed."@en ;
  schema:url <https://onco.cc/trials/nct04417530/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04417530> ;
  onco:status "completed" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/uveal-melanoma/> ;
  onco:drugs <https://onco.cc/drugs/belzupacap-sarotalocan/> ;
  onco:companies <https://onco.cc/companies/aura-biosciences/> .